Tang, L., Li, P., & Li, L. (2025). Glypican-4 trajectory predicts the risk of gestational diabetes mellitus and the requirement for insulin therapy during pregnancy. Frontiers in endocrinology (Lausanne), 16, 1483567. https://doi.org/10.3389/fendo.2025.1483567
Chicago Style (17th ed.) CitationTang, Lei, Ping Li, and Ling Li. "Glypican-4 Trajectory Predicts the Risk of Gestational Diabetes Mellitus and the Requirement for Insulin Therapy During Pregnancy." Frontiers in Endocrinology (Lausanne) 16 (2025): 1483567. https://doi.org/10.3389/fendo.2025.1483567.
MLA (9th ed.) CitationTang, Lei, et al. "Glypican-4 Trajectory Predicts the Risk of Gestational Diabetes Mellitus and the Requirement for Insulin Therapy During Pregnancy." Frontiers in Endocrinology (Lausanne), vol. 16, 2025, p. 1483567, https://doi.org/10.3389/fendo.2025.1483567.